Fundz

Centivax And U.S. Naval Medical Research Center Announce Strategic Partnership To Initiate Clinical Development Of A Broad-Spectrum Injectable For Covid-19, With $4.2M From The Henry Jackson Foundation

PRIVATEJun 02, 2021

Round Type

Funding Round

South San FranciscoBiotechnologyHealth Care

Description

Centivax Inc. announced today that it has entered into a strategic partnership with the U.S. Naval Medical Research Center (NMRC) for Phase I clinical development of Centi-B9, Centivax's SARS-CoV-2 broad-spectrum injectable antibody therapeutic and prophylactic. Centi-B9 has been engineered to broadly neutralize the mutated emerging coronavirus variants, with demonstrated broad-spectrum reactivity against 99.5% of all coronavirus variants in the U.S.A, and over 98% of coronavirus variants globally, including critical mutations found in the UK B.1.1.7, South African B.1.351, Brazilian P.1, New York B.1.526 and California B.1.429 strains

Quick answer

Centivax raised an undisclosed amount in a Funding Round round, dated June 2, 2021. Centivax is based in South San Francisco, California, United States.

How much did Centivax raise?
Centivax raised an undisclosed amount in a Funding Round round on June 2, 2021.
What does Centivax do?
Centivax is a South San Francisco-based biotechnology company founded in 2020, focused on advancing global health through broad-spectrum vaccines and antivenoms.
Where is Centivax based and how big is it?
Centivax is based in South San Francisco, California, United States. Fundz records about 27 employees.
Who are the decision-makers at Centivax?
Fundz holds 1 contact at Centivax, including the Chief Science Officer (CSO)-Co-Founder. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology and Health Care around the same time

Companies in the same sectors as Centivax that raised within 45 days of this round, from Fundz verified event records.

  • Tellus Therapeutics raised $2M (Seed) on July 16, 2021.
  • OM1 raised $85M on July 16, 2021.
  • OM1 raised $85M (Funding Round) on July 16, 2021.
  • SynerFuse, Inc. raised $275K (Seed) on July 15, 2021.
  • Tenon Medical raised $12M on July 15, 2021.
  • Telo Genomics raised $81K (Pre-Seed) on July 15, 2021.

Who to call at Centivax, and when

A new round usually means Centivax is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Centivax raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Centivax, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Centivax. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Centivax

Location

South San Francisco, California, United States

About

Centivax is a South San Francisco-based biotechnology company founded in 2020, focused on advancing global health through broad-spectrum vaccines and antivenoms. Its lead candidate, Centi-Flu, is a universal flu vaccine in pre-clinical development, supported by a partnership with Emery Pharma. Centivax also develops anti-venoms and anti-infectives to combat emerging health threats. Led by CEO Jacob Glanville, the company has raised $10.99 million from investors including the Bill & Melinda Gates Foundation.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Centivax raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsSawsan Y., Chief Science Officer (CSO)-Co-Founder hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Centivax's next move

See what Strategic adds

Centivax raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.